Abstract
A wide range of liver diseases manifest as biliary obstruction, or cholestasis. However, the sequence of molecular events triggered as part of the early hepatocellular homeostatic response to abnormal elevations in biliary pressure remains poorly elucidated. Bile canaliculi are dynamic luminal structures that undergo actomyosin-mediated periodic contractions to propel secreted bile. Additionally, pericanalicular actin is accumulated during obstructive cholestasis. Therefore, we hypothesize that the pericanalicular actin cortex undergoes significant remodeling as a regulatory response against increased biliary pressure. Here, we report that, actomyosin contractility induces transient deformations along the canalicular membrane, a process we have termed inward blebbing. We show that these membrane intrusions are initiated by local ruptures in the pericanalicular actin cortex, and they typically retract following repair by actin polymerization and actomyosin contraction. However, above a certain osmotic pressure threshold, these inward blebs pinch away from the canalicular membrane into the hepatocyte cytoplasm as large vesicles (2-8 µm). Importantly, we show that these vesicles aid in the regurgitation of bile from the canalicular system. Conclusion: Actomyosin contractility induces the formation of bile-regurgitative vesicles, thus serving as an early homeostatic mechanism against increased biliary pressure during cholestasis.
Footnotes
↵a Co-first authors
↵b Co-senior authors
- List of Abbreviations
- ICP
- Intracanalicular pressure
- PAC
- Pericanalicular actin cortex BC: Bile canaliculi
- BDL
- Bile duct ligation
- IB
- Inward blebs
- BCV
- Bile canaliculi-derived vesicles
- UDCA
- Ursodeoxycholic acid
- CLF
- Cholyl-lysyl-fluorescein
- GFP
- Green fluorescent protein
- RFP
- Red fluorescent protein
- SEM
- Standard error of the mean
Financial Support: Mechanobiology Institute (National University of Singapore, Singapore, Grant number: R-714-006-008-271), Institute of Bioengineering and Nanotechnology (A*STAR, Singapore), Singapore-MIT Alliance for Research and Technology, National Medical Research Council (Ministry of Health, Singapore, Grant Number: R-185-000-294-511) and Joint Council Development Program (A*STAR, Singapore, Project Number 1334i00051)